Vertero
Woburn
About Vertero
Vertero's differentiated therapy development pipeline focuses on the peripheral nervous system, delaying the onset and slowing the progression of difficult illnesses including Parkinson's.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $130.9M
- Funding stage: Late Stage Venture
- Last round: Series D (Oct 2025)
- Website: vertero.com
- Phone: 617-874-5260
Industries & Categories
Biopharma, Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/vertero-32667 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.